Skip to main content

Table 5 Association between cholesterol and HAART initiation, adjusted for the potential confounding factors of study participants at Burayu Health Center, Addis Ababa, Ethiopia, 2012

From: Antiretroviral treatment associated hyperglycemia and dyslipidemia among HIV infected patients at Burayu Health Center, Addis Ababa, Ethiopia: a cross-sectional comparative study

Variables Lipid profile levels
TC ≥200 mg/dl HDL < 40 mg/dl LDL ≥130 mg/dl
AOR (95% CI) AOR (95% CI) AOR (95% CI)
Non-HAART* 1.00 1.00 1.00
HAART Initiated 5.46(2.81-10.61) 2.62(1.55-4.44) 3.89(1.76-8.61)
P-value <0.0001 <0.0001 0.001
BMI ≤21.2* 1.00 1.00 1.00
BMI >21.2 1.90(1.03-3.50)   
P-value 0.039   
  1. HAART, highly active antiretroviral therapy; AOR, adjusted odds ratio; CI, confidence interval; BMI, body mass index; TC, total cholesterol; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; p, significance level; *Reference category.